Thrombosis and Haemostasis, Table of Contents Thromb Haemost 2005; 93(01): 35-39DOI: 10.1160/TH04-06-0393 Blood Coagulation, Fibrinolysis and Cellular Haemostasis Schattauer GmbH Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction Authors Author Affiliations Birgit Steppich 1 Deutsches Herzzentrum und 1. Medizinische Klinik der Technischen Universität München, Germany Christoph Mattisek 1 Deutsches Herzzentrum und 1. Medizinische Klinik der Technischen Universität München, Germany Dean Sobczyk 1 Deutsches Herzzentrum und 1. Medizinische Klinik der Technischen Universität München, Germany Adnan Kastrati 1 Deutsches Herzzentrum und 1. Medizinische Klinik der Technischen Universität München, Germany Albert Schömig 1 Deutsches Herzzentrum und 1. Medizinische Klinik der Technischen Universität München, Germany Ilka Ott 1 Deutsches Herzzentrum und 1. Medizinische Klinik der Technischen Universität München, Germany Recommend Article Abstract Full Text PDF Download(opens in new window) Keywords KeywordsTissue factor pathway inhibitor (TFPI) - Ischaemic heart disease - hypercoagulability References References 1 Keeley E, Boura J, Grines C. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20. 2 Ott I. et al Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositolanchored tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 2000; 20: 874-82. 3 Ott I. et al Proteolysis of tissue factor pathway inhibitor- 1 by thrombolysis in acute myocardial infarction. Circulation 2002; 105: 279-81. 4 Ott I, Andrassy M, Zieglgansberger D. et al Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1. Blood 2001; 97: 3721-6. 5 Soejima H, Ogawa H, Yasue H. et al Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation 1999; 99: 2908-13. 6 Giesen PL, Rauch U, Bohrmann B. et al Bloodborne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A. 1999; 96: 2311-5. 7 Bogdanov V. et al Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9: 458-62. 8 Mallat Z. et al Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841-3. 9 Schomig A. et al Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus thrombolysis for occluded coronary arteries in patients with acute myocardial infarction study investigators. N Engl J Med. 2000; 343: 385-91. 10 Combes V, Simon A, Grau G. et al In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102. 11 Kato H. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects. Arterioscler Thromb Vasc Biol 2002; 22: 539-48. 12 Nieuwland R. et al Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95: 930-5. 13 Li A, Wun TC. Proteolysis of tissue factor pathway inhibitor (TFPI) by plasmin: effect on TFPI activity. Thromb Haemost 1998; 80: 423-7. 14 Higuchi DA, Wun TC, Likert KM. et al The effect of leukocyte elastase on tissue factor pathway inhibitor. Blood 1992; 79: 1712-9. 15 Belaaouaj A, Li A, Wun T. et al Matrix metalloproteinases cleave tissue factor pathway inhibitor: effects on coagulation. J Biol Chem 2000; 275 (35) 27123-8. 16 Ott I. et al Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. Am J Cardiol 1998; 82: 938-42. 17 Rauch U, Nemerson Y. Circulating tissue factor and thrombosis. Curr Opin Hematol 2000; 7: 273-7. 18 Falati S, Liu Q, Gross P. et al Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197: 1585-98. 19 Fassbender K, Dempfle CE, Mielke O. et al Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator. Stroke 1999; 30: 2101-4. 20 Steiner S, Ahmadi R, Willfort A. et al Hemostatic markers with bolus versus prolonged heparin after carotid artery stenting. Thromb Res 2003; 109: 23-9. 21 Lupu C. et al Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture. Arterioscler Thromb Vasc Biol 1999; 19: 2251-62. 22 Stalboerger PG. et al Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor. Thromb Haemost 2001; 86: 923-8. 23 Li Y, Spencer FA, Becker RCJ. Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor. Thromb Thrombolysis 2003; 15: 19-23. 24 Leon C, Alex M, Klocke A. et al Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 2004; 103: 594-600.
